1. Pinheiro TP, Silva CC, Silveira CS, Botelho PC, Pinheiro Md, Pinheiro Jde J. Progressive hemifacial atrophy--case report. Med Oral Patol Oral Cir Bucal. 2006; 11:E112–E114. PMID:
16505785.
2. Patel H, Thakkar C, Patel K. Parry-Romberg syndrome: a rare entity. J Maxillofac Oral Surg. 2010; 9:247–250. PMID:
22190798.
Article
3. Wartenberg R. Progressive facial hemiatrophy. Arch Neurol Psychiatry. 1945; 54:75–96.
Article
4. Sande A, Risbud M, Kshar A, Paranjpe AO. Progressive hemifacial atrophy. Dent Res J (Isfahan). 2013; 10:108–111. PMID:
23878573.
5. Al-Aizari NA, Azzeghaiby SN, Al-Shamiri HM, Darwish S, Tarakji B. Oral manifestations of Parry-Romberg syndrome: a review of literature. Avicenna J Med. 2015; 5:25–28. PMID:
25878963.
Article
6. Panda AK, Gopinath G, Singh S. Parry-Romberg syndrome with hemimasticatory spasm in pregnancy; a dystonia mimic. J Neurosci Rural Pract. 2014; 5:184–186. PMID:
24966565.
Article
7. Goyal S, Goyal S. Pattern of dental malocclusion in orthodontic patients in rwanda: a retrospective hospital based study. Rwanda Med J. 2012; 69:13–18.
8. Ebersbach G, Kabus C, Schelosky L, Terstegge L, Poewe W. Hemimasticatory spasm in hemifacial atrophy: diagnostic and therapeutic aspects in two patients. Mov Disord. 1995; 10:504–507. PMID:
7565834.
Article
9. Kim HJ, Jeon BS, Lee KW. Hemimasticatory spasm associated with localized scleroderma and facial hemiatrophy. Arch Neurol. 2000; 57:576–580. PMID:
10768634.
Article
10. Cersósimo MG, Bertoti A, Roca CU, Micheli F. Botulinum toxin in a case of hemimasticatory spasm with severe worsening during pregnancy. Clin Neuropharmacol. 2004; 27:6–8. PMID:
15090929.
Article
11. Teive HA, Piovesan EJ, Germiniani FM, Camargo CH, Sa D, Scola RH, et al. Hemimasticatory spasm treated with botulinum toxin: case report. Arq Neuropsiquiatr. 2002; 60:288–289. PMID:
12068362.
Article
12. Rosenstengel C, Matthes M, Baldauf J, Fleck S, Schroeder H. Hemifacial spasm: conservative and surgical treatment options. Dtsch Arztebl Int. 2012; 109:667–673. PMID:
23264807.
13. Nayyar P, Kumar P, Nayyar PV, Singh A. BOTOX: broadening the horizon of dentistry. J Clin Diagn Res. 2014; 8:ZE25–ZE29.
14. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998; 21:1740–1747. PMID:
9843077.
Article
15. Mukkannavar PB. Effect of combination therapy [TENS & ultrasound] and ischemic compression in the treatment of active myofascial trigger points. J Exerc Sci Physiother. 2008; 4:95–103.
16. Kasat V, Gupta A, Ladda R, Kathariya M, Saluja H, Farooqui AA. Transcutaneous electric nerve stimulation (TENS) in dentistry: a review. J Clin Exp Dent. 2014; 6:e562–e568. PMID:
25674327.
Article
17. Singh R, Rao K, Anap D, Iyer C, Khatri S. The short term effect of TheraBite® on temporomandibular dysfunction: a case study. Int J Phys Med Rehabil. 2013; 1:102.
Article
18. Pal US, Kumar L, Mehta G, Singh N, Singh G, Singh M, et al. Trends in management of myofacial pain. Natl J Maxillofac Surg. 2014; 5:109–116. PMID:
25937719.
Article
19. Rajalakshmi A, Sathish KM, Ivvala AS, Mahalakshmi R. Effect of transcutaneous electrical nerve stimulation in trapezitis. Int J Physiother Res. 2013; 1:205–207.